位置:首页 > 蛋白库 > TRXR3_MOUSE
TRXR3_MOUSE
ID   TRXR3_MOUSE             Reviewed;         652 AA.
AC   Q99MD6; Q9CZE5;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2013, sequence version 3.
DT   03-AUG-2022, entry version 144.
DE   RecName: Full=Thioredoxin reductase 3;
DE            EC=1.8.1.9;
DE   AltName: Full=Thioredoxin and glutathione reductase;
DE   AltName: Full=Thioredoxin reductase TR2;
GN   Name=Txnrd3 {ECO:0000312|MGI:MGI:2386711};
GN   Synonyms=Tgr {ECO:0000312|EMBL:AAK31172.1}, Trxr3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAK31172.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBCELLULAR LOCATION, DOMAIN, 3D-STRUCTURE MODELING, AND SELENOCYSTEINE AT
RP   SEC-651.
RX   PubMed=11259642; DOI=10.1073/pnas.051454398;
RA   Sun Q.-A., Kirnarsky L., Sherman S., Gladyshev V.N.;
RT   "Selenoprotein oxidoreductase with specificity for thioredoxin and
RT   glutathione systems.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:3673-3678(2001).
RN   [2] {ECO:0000312|EMBL:BAB28419.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAB28419.1};
RC   TISSUE=Embryo {ECO:0000312|EMBL:BAB28419.1}, and
RC   Thymus {ECO:0000312|EMBL:BAC37890.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAH76605.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:AAH76605.1};
RC   TISSUE=Brain {ECO:0000312|EMBL:AAH76605.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305}
RP   PROTEIN SEQUENCE OF 191-202 AND 550-561, AND TISSUE SPECIFICITY.
RX   PubMed=10455115; DOI=10.1074/jbc.274.35.24522;
RA   Sun Q.-A., Wu Y., Zappacosta F., Jeang K.-T., Lee B.J., Hatfield D.L.,
RA   Gladyshev V.N.;
RT   "Redox regulation of cell signaling by selenocysteine in mammalian
RT   thioredoxin reductases.";
RL   J. Biol. Chem. 274:24522-24530(1999).
RN   [5] {ECO:0000305}
RP   DOMAIN, AND MUTAGENESIS OF SEC-651 AND 651-SEC-GLY-652.
RX   PubMed=16262253; DOI=10.1021/bi051321w;
RA   Sun Q.-A., Su D., Novoselov S.V., Carlson B.A., Hatfield D.L.,
RA   Gladyshev V.N.;
RT   "Reaction mechanism and regulation of mammalian thioredoxin/glutathione
RT   reductase.";
RL   Biochemistry 44:14528-14537(2005).
RN   [6] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=15901730; DOI=10.1074/jbc.m503638200;
RA   Su D., Novoselov S.V., Sun Q.-A., Moustafa M.E., Zhou Y., Oko R.,
RA   Hatfield D.L., Gladyshev V.N.;
RT   "Mammalian selenoprotein thioredoxin-glutathione reductase. Roles in
RT   disulfide bond formation and sperm maturation.";
RL   J. Biol. Chem. 280:26491-26498(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Heart, Kidney, Lung, Pancreas, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [8]
RP   NON-AUG INITIATOR START CODON, AND TISSUE SPECIFICITY.
RX   PubMed=20018845; DOI=10.1074/jbc.m109.070532;
RA   Gerashchenko M.V., Su D., Gladyshev V.N.;
RT   "CUG start codon generates thioredoxin/glutathione reductase isoforms in
RT   mouse testes.";
RL   J. Biol. Chem. 285:4595-4602(2010).
RN   [9]
RP   SUCCINYLATION [LARGE SCALE ANALYSIS] AT LYS-388, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [10]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-34, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Embryo;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Displays thioredoxin reductase, glutaredoxin and glutathione
CC       reductase activities. Catalyzes disulfide bond isomerization. Promotes
CC       disulfide bond formation between GPX4 and various sperm proteins and
CC       may play a role in sperm maturation by promoting formation of sperm
CC       structural components. {ECO:0000269|PubMed:11259642,
CC       ECO:0000269|PubMed:15901730}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[thioredoxin]-dithiol + NADP(+) = [thioredoxin]-disulfide +
CC         H(+) + NADPH; Xref=Rhea:RHEA:20345, Rhea:RHEA-COMP:10698, Rhea:RHEA-
CC         COMP:10700, ChEBI:CHEBI:15378, ChEBI:CHEBI:29950, ChEBI:CHEBI:50058,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.8.1.9;
CC         Evidence={ECO:0000269|PubMed:11259642};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000250|UniProtKB:O89049};
CC       Note=Binds 1 FAD per subunit. {ECO:0000250|UniProtKB:O89049};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=14.7 uM for 5,5'-dithiobis(2-nitrobenzoic acid)
CC         {ECO:0000269|PubMed:11259642};
CC         KM=10.7 uM for NADPH {ECO:0000269|PubMed:11259642};
CC         KM=3.0 uM for thioredoxin {ECO:0000269|PubMed:11259642};
CC         KM=8.84 uM for oxidized glutathione {ECO:0000269|PubMed:11259642};
CC         KM=45.2 uM for beta-hydroxyethyl disulfide
CC         {ECO:0000269|PubMed:11259642};
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:O89049}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11259642,
CC       ECO:0000269|PubMed:15901730}. Nucleus {ECO:0000269|PubMed:11259642,
CC       ECO:0000269|PubMed:15901730}. Microsome {ECO:0000269|PubMed:11259642,
CC       ECO:0000269|PubMed:15901730}. Endoplasmic reticulum. Note=Detected in
CC       cytoplasm and nucleus in late spermatids. {ECO:0000269|PubMed:11259642,
CC       ECO:0000269|PubMed:15901730}.
CC   -!- TISSUE SPECIFICITY: Expressed preferentially in testis where it is
CC       found in spermatids and spermatocytes but not in sperm. In elongating
CC       spermatids, expressed at the site of mitochondrial sheath formation.
CC       Low levels in other tissues including heart, lung, liver, kidney,
CC       brain, muscle and prostate. {ECO:0000269|PubMed:10455115,
CC       ECO:0000269|PubMed:15901730, ECO:0000269|PubMed:20018845}.
CC   -!- DEVELOPMENTAL STAGE: Accumulates in the testis after puberty. Not
CC       detected in 20-day-old mice but highly expressed in testes of 7-month-
CC       old mice. {ECO:0000269|PubMed:15901730}.
CC   -!- DOMAIN: The N-terminal glutaredoxin domain does not contain the C-X-X-C
CC       redox-active motif normally found in glutaredoxins but activity may be
CC       mediated through a single cysteine. The C-terminal Cys-Sec motif of one
CC       subunit of the homodimer may transfer electrons from the thiol-
CC       disulfide center to the glutaredoxin domain of the other subunit.
CC       {ECO:0000269|PubMed:11259642, ECO:0000269|PubMed:16262253}.
CC   -!- MISCELLANEOUS: The thioredoxin reductase active site is a redox-active
CC       disulfide bond. The selenocysteine residue is also essential for
CC       catalytic activity (By similarity). {ECO:0000250|UniProtKB:Q16881}.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   -!- CAUTION: This sequence initiates at a CTG codon.
CC       {ECO:0000305|PubMed:20018845}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH76605.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH76605.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon.; Evidence={ECO:0000305};
CC       Sequence=AAK31172.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB28419.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB28419.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAB28419.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon.; Evidence={ECO:0000305};
CC       Sequence=BAC37890.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC37890.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF349659; AAK31172.1; ALT_INIT; mRNA.
DR   EMBL; AK012699; BAB28419.1; ALT_SEQ; mRNA.
DR   EMBL; AK080362; BAC37890.1; ALT_SEQ; mRNA.
DR   EMBL; BC076605; AAH76605.1; ALT_SEQ; mRNA.
DR   RefSeq; NP_001171529.1; NM_001178058.1.
DR   RefSeq; NP_694802.2; NM_153162.3.
DR   PDB; 2LV3; NMR; -; A=44-161.
DR   PDBsum; 2LV3; -.
DR   BMRB; Q99MD6; -.
DR   SMR; Q99MD6; -.
DR   STRING; 10090.ENSMUSP00000000828; -.
DR   iPTMnet; Q99MD6; -.
DR   PhosphoSitePlus; Q99MD6; -.
DR   jPOST; Q99MD6; -.
DR   MaxQB; Q99MD6; -.
DR   PaxDb; Q99MD6; -.
DR   PeptideAtlas; Q99MD6; -.
DR   PRIDE; Q99MD6; -.
DR   ProteomicsDB; 297530; -.
DR   DNASU; 232223; -.
DR   GeneID; 232223; -.
DR   KEGG; mmu:232223; -.
DR   UCSC; uc009cwj.1; mouse.
DR   CTD; 114112; -.
DR   MGI; MGI:2386711; Txnrd3.
DR   eggNOG; KOG1752; Eukaryota.
DR   eggNOG; KOG4716; Eukaryota.
DR   InParanoid; Q99MD6; -.
DR   OrthoDB; 581771at2759; -.
DR   BRENDA; 1.8.1.B1; 3474.
DR   SABIO-RK; Q99MD6; -.
DR   BioGRID-ORCS; 232223; 2 hits in 72 CRISPR screens.
DR   PRO; PR:Q99MD6; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q99MD6; protein.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0097573; F:glutathione oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0004791; F:thioredoxin-disulfide reductase activity; IDA:MGI.
DR   GO; GO:0001825; P:blastocyst formation; IMP:MGI.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0045454; P:cell redox homeostasis; IBA:GO_Central.
DR   GO; GO:0006749; P:glutathione metabolic process; IDA:MGI.
DR   GO; GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR002109; Glutaredoxin.
DR   InterPro; IPR011899; Glutaredoxin_euk/vir.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR006338; Thioredoxin/glutathione_Rdtase.
DR   Pfam; PF00462; Glutaredoxin; 1.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR02180; GRX_euk; 1.
DR   TIGRFAMs; TIGR01438; TGR; 1.
DR   PROSITE; PS51354; GLUTAREDOXIN_2; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Developmental protein; Differentiation;
KW   Direct protein sequencing; Disulfide bond; Electron transport;
KW   Endoplasmic reticulum; FAD; Flavoprotein; Methylation; Microsome; NADP;
KW   Nucleus; Oxidoreductase; Phosphoprotein; Redox-active center;
KW   Reference proteome; Selenocysteine; Spermatogenesis; Transport.
FT   CHAIN           1..652
FT                   /note="Thioredoxin reductase 3"
FT                   /id="PRO_0000320696"
FT   DOMAIN          65..165
FT                   /note="Glutaredoxin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00686"
FT   REGION          1..62
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..15
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        625
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         167..196
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250"
FT   NON_STD         651
FT                   /note="Selenocysteine"
FT   MOD_RES         34
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         34
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         50
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86VQ6"
FT   MOD_RES         388
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   DISULFID        212..217
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        650..651
FT                   /note="Cysteinyl-selenocysteine (Cys-Sec)"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         651..652
FT                   /note="Missing: Abolishes thioredoxin reductase,
FT                   glutaredoxin and gluthioine reductase activities."
FT                   /evidence="ECO:0000269|PubMed:16262253"
FT   MUTAGEN         651
FT                   /note="U->C: Thioredoxin reductase activity reduced to 21%.
FT                   Glutaredoxin activity reduced to 14%. Glutathione reductase
FT                   activity reduced to 18%."
FT                   /evidence="ECO:0000269|PubMed:16262253"
FT   MUTAGEN         651
FT                   /note="U->S: Abolishes thioredoxin reductase, glutaredoxin
FT                   and gluthioine reductase activities."
FT                   /evidence="ECO:0000269|PubMed:16262253"
FT   CONFLICT        8
FT                   /note="P -> R (in Ref. 2; BAB28419)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        16
FT                   /note="S -> W (in Ref. 2; BAB28419)"
FT                   /evidence="ECO:0000305"
FT   HELIX           61..74
FT                   /evidence="ECO:0007829|PDB:2LV3"
FT   STRAND          75..81
FT                   /evidence="ECO:0007829|PDB:2LV3"
FT   TURN            86..89
FT                   /evidence="ECO:0007829|PDB:2LV3"
FT   HELIX           90..97
FT                   /evidence="ECO:0007829|PDB:2LV3"
FT   STRAND          103..106
FT                   /evidence="ECO:0007829|PDB:2LV3"
FT   TURN            107..109
FT                   /evidence="ECO:0007829|PDB:2LV3"
FT   HELIX           113..124
FT                   /evidence="ECO:0007829|PDB:2LV3"
FT   STRAND          126..128
FT                   /evidence="ECO:0007829|PDB:2LV3"
FT   STRAND          133..136
FT                   /evidence="ECO:0007829|PDB:2LV3"
FT   HELIX           144..151
FT                   /evidence="ECO:0007829|PDB:2LV3"
FT   HELIX           155..159
FT                   /evidence="ECO:0007829|PDB:2LV3"
SQ   SEQUENCE   652 AA;  71319 MW;  AC6342C64DDEC1BC CRC64;
     MEKPPSPPPP PRAQTSPGLG KVGVLPNRRL GAVRGGLMSS PPGRRARLAS PGTSRPSSEA
     REELRRRLRD LIEGNRVMIF SKSYCPHSTR VKELFSSLGV VYNILELDQV DDGASVQEVL
     TEISNQKTVP NIFVNKVHVG GCDRTFQAHQ NGLLQKLLQD DSAHDYDLII IGGGSGGLSC
     AKEAANLGKK VMVLDFVVPS PQGTTWGLGG TCVNVGCIPK KLMHQAALLG HALQDAKKYG
     WEYNQQVKHN WEAMTEAIQS HIGSLNWGYR VTLREKGVTY VNSFGEFVDL HKIKATNKKG
     QETFYTASKF VIATGERPRY LGIQGDKEYC ITSDDLFSLP YCPGCTLVVG ASYVGLECAG
     FLAGLGLDVT VMVRSVLLRG FDQEMAEKVG SYLEQQGVKF QRKFTPILVQ QLEKGLPGKL
     KVVAKSTEGP ETVEGIYNTV LLAIGRDSCT RKIGLEKIGV KINEKNGKIP VNDVEQTNVP
     HVYAIGDILD GKPELTPVAI QAGKLLARRL FGVSLEKCDY INIPTTVFTP LEYGCCGLSE
     EKAIEMYKKE NLEVYHTLFW PLEWTVAGRD NNTCYAKIIC NKFDNERVVG FHLLGPNAGE
     ITQGFAAAMK CGLTKQLLDD TIGIHPTCGE VFTTLEITKS SGLDITQKGC UG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024